- Home
- YMAB vs MYD Comparison
YMAB vs MYD Comparison
Compare YMAB & MYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- MYD
- Stock Information
- Founded
- YMAB 2015
- MYD 1991
- Country
- YMAB United States
- MYD United States
- Employees
- YMAB N/A
- MYD N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- MYD Investment Bankers/Brokers/Service
- Sector
- YMAB Health Care
- MYD Finance
- Exchange
- YMAB Nasdaq
- MYD Nasdaq
- Market Cap
- YMAB 386.7M
- MYD 460.1M
- IPO Year
- YMAB 2018
- MYD N/A
- Fundamental
- Price
- YMAB $8.57
- MYD $10.03
- Analyst Decision
- YMAB Buy
- MYD
- Analyst Count
- YMAB 10
- MYD 0
- Target Price
- YMAB $13.91
- MYD N/A
- AVG Volume (30 Days)
- YMAB 2.2M
- MYD 253.1K
- Earning Date
- YMAB 08-08-2025
- MYD 01-01-0001
- Dividend Yield
- YMAB N/A
- MYD 4.55%
- EPS Growth
- YMAB N/A
- MYD N/A
- EPS
- YMAB N/A
- MYD N/A
- Revenue
- YMAB $85,385,000.00
- MYD N/A
- Revenue This Year
- YMAB N/A
- MYD N/A
- Revenue Next Year
- YMAB $13.97
- MYD N/A
- P/E Ratio
- YMAB N/A
- MYD N/A
- Revenue Growth
- YMAB N/A
- MYD N/A
- 52 Week Low
- YMAB $3.55
- MYD $8.76
- 52 Week High
- YMAB $16.11
- MYD $11.30
- Technical
- Relative Strength Index (RSI)
- YMAB 81.31
- MYD 53.41
- Support Level
- YMAB $8.50
- MYD $9.91
- Resistance Level
- YMAB $8.56
- MYD $10.06
- Average True Range (ATR)
- YMAB 0.02
- MYD 0.05
- MACD
- YMAB -0.12
- MYD 0.00
- Stochastic Oscillator
- YMAB 83.33
- MYD 51.96
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About MYD Blackrock MuniYield Fund Inc.
Blackrock Muniyield Fund Inc is a non-diversified, closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.